1990
DOI: 10.1016/1043-4666(90)90025-o
|View full text |Cite
|
Sign up to set email alerts
|

Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

1992
1992
2017
2017

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 55 publications
(28 citation statements)
references
References 22 publications
0
28
0
Order By: Relevance
“…This may mean that monocytes were activated to a greater extent during hemodialysis with RC membranes than during push/pull HDF with PS membranes, when the LPS level in dialysate was kept undetectable by a Limulus assay. To our knowledge, however, for the detection of LAL-negative pyrogens such as low-molecular-weight fragment of LPS a bioassay is needed to determine monocyte activation such as the production and release of cytokines from monocytes during treatment [25, 31]. We consider that this study was also a bioassay, since changes in Mac-1 and CD14 expression on monocytes and serum CD14 level may be considered as markers of monocyte activation [1, 2, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18].…”
Section: Discussionmentioning
confidence: 99%
“…This may mean that monocytes were activated to a greater extent during hemodialysis with RC membranes than during push/pull HDF with PS membranes, when the LPS level in dialysate was kept undetectable by a Limulus assay. To our knowledge, however, for the detection of LAL-negative pyrogens such as low-molecular-weight fragment of LPS a bioassay is needed to determine monocyte activation such as the production and release of cytokines from monocytes during treatment [25, 31]. We consider that this study was also a bioassay, since changes in Mac-1 and CD14 expression on monocytes and serum CD14 level may be considered as markers of monocyte activation [1, 2, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18].…”
Section: Discussionmentioning
confidence: 99%
“…Hansen et al (1999) found that LPS from Escherichia coli and Salmonella enteritis was about four times more potent than that from Klebsiella pneumoniae and Pseudomonas aeruginosa. Laude-Sharp et al (1990) found that E. coli LPS is about 100 times more potent than Shigella flexneri LPS and Pseudomonas testosteroni LPS is about 60% more active than E. coli LPS. Even within species there can be wide variations in LAL potency with a 625-fold range in some E. coli serotypes (Koyama et al 2000).…”
Section: Impeller Humidifiermentioning
confidence: 99%
“…This could be attributable to the species of bacteria generating the endotoxin, the amount of endotoxin actually respired, the size of particles with which the endotoxin is associated, and/or individual response variability (e.g. et al 1990;Hansen et al 1999;Koyama et al 2000). Table 1 summarizes some controlled laboratory studies involving human volunteers.…”
Section: Laboratory Endotoxin Inhalation Studies In Humansmentioning
confidence: 99%
“…The tumor necrosis factor alpha (TNF-α) production by human mononuclear cells was suppressed incompletely by polymyxin B, a nonspecific inhibitor of lipid A and LPS. Pereira et al [7]reported that bacterial cytokine-inducing substances from Pseudomonas aeruginosa were also not suppressed by polymyxin B. Laude-Sharp et al [8]presented experimental data showing that interleukin (IL) 1 inducing substances from gram-negative bacteria did not respond to Limulus amebocyte assay, a method to detect endotoxin and β-glucan, a component of fungi.…”
Section: Introductionmentioning
confidence: 99%